Eversept Partners, LP Biogen Inc. Call Options Transaction History

Eversept Partners, LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 08, 2023	SELL	$194.69 - $268.46 $20 Million - $27.6 Million	-102,900 Reduced 73.5%	37,100 $9.91 Million
Q1 2022 Nov 08, 2023	BUY	$193.77 - $244.14 $27.1 Million - $34.2 Million	140,000 New	140,000 $29.5 Million
Q2 2021 Nov 08, 2023	BUY	$259.0 - $414.71 $29.9 Million - $47.9 Million	115,600 New	115,600 $40 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.